SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014632
Filing Date
2021-11-04
Accepted
2021-11-04 16:41:26
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20210930x10q.htm   iXBRL 10-Q 1211367
2 EX-10.1 nxtc-20210930xex10d1.htm EX-10.1 9346
3 EX-31.1 nxtc-20210930xex31d1.htm EX-31.1 12904
4 EX-31.2 nxtc-20210930xex31d2.htm EX-31.2 12700
5 EX-32.1 nxtc-20210930xex32d1.htm EX-32.1 12251
  Complete submission text file 0001558370-21-014632.txt   4646972

Data Files

Seq Description Document Type Size
6 EX-101.SCH nxtc-20210930.xsd EX-101.SCH 24274
7 EX-101.CAL nxtc-20210930_cal.xml EX-101.CAL 36009
8 EX-101.DEF nxtc-20210930_def.xml EX-101.DEF 87281
9 EX-101.LAB nxtc-20210930_lab.xml EX-101.LAB 280242
10 EX-101.PRE nxtc-20210930_pre.xml EX-101.PRE 187384
11 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20210930x10q_htm.xml XML 839925
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 211380531
SIC: 2834 Pharmaceutical Preparations